tetano
Editor, Senior Moderator
Virulence
. 2022 Dec;13(1):1076-1087.
doi: 10.1080/21505594.2022.2090071.
The impact of infection with COVID-19 on the respiratory microbiome: A narrative review
Taiping Zhu[SUP] 1 [/SUP], Jun Jin[SUP] 2 [/SUP], Minhua Chen[SUP] 2 [/SUP], Yingjun Chen[SUP] 3 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has affected millions of individuals with various implications. Consistent with the crucial role of the microbiome in determining health and disease in humans, various studies have investigated the gut and respiratory microbiome effect on the COVID-19. Microbiota dysbiosis might support the entry, replication, and establishment of SARS-CoV-2 infection by modulating various mechanisms. One of the main mechanisms that the modulation of respiratory microbiota composition during the COVID-19 infection affects the magnitude of the disease is changes in innate and acquired immune responses, including inflammatory markers and cytokines and B- and T-cells. The diversity of respiratory microbiota in COVID-19 patients is controversial; some studies reported low microbial diversity, while others found high diversity, suggesting the role of respiratory microbiota in this disease. Modulating microbiota diversity and profile by supplementations and nutrients can be applied prophylactic and therapeutic in combating COVID-19. Here, we discussed the lung microbiome dysbiosis during various lung diseases and its interaction with immune cells, focusing on COVID-19.
Keywords: COVID-19; immune responses; microbiome; microbiome dysbiosis; respiratory microbiome.
. 2022 Dec;13(1):1076-1087.
doi: 10.1080/21505594.2022.2090071.
The impact of infection with COVID-19 on the respiratory microbiome: A narrative review
Taiping Zhu[SUP] 1 [/SUP], Jun Jin[SUP] 2 [/SUP], Minhua Chen[SUP] 2 [/SUP], Yingjun Chen[SUP] 3 [/SUP]
Affiliations
- PMID: 35763685
- DOI: 10.1080/21505594.2022.2090071
Abstract
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has affected millions of individuals with various implications. Consistent with the crucial role of the microbiome in determining health and disease in humans, various studies have investigated the gut and respiratory microbiome effect on the COVID-19. Microbiota dysbiosis might support the entry, replication, and establishment of SARS-CoV-2 infection by modulating various mechanisms. One of the main mechanisms that the modulation of respiratory microbiota composition during the COVID-19 infection affects the magnitude of the disease is changes in innate and acquired immune responses, including inflammatory markers and cytokines and B- and T-cells. The diversity of respiratory microbiota in COVID-19 patients is controversial; some studies reported low microbial diversity, while others found high diversity, suggesting the role of respiratory microbiota in this disease. Modulating microbiota diversity and profile by supplementations and nutrients can be applied prophylactic and therapeutic in combating COVID-19. Here, we discussed the lung microbiome dysbiosis during various lung diseases and its interaction with immune cells, focusing on COVID-19.
Keywords: COVID-19; immune responses; microbiome; microbiome dysbiosis; respiratory microbiome.